The genetics of multiple sclerosis: SNPs to pathways to pathogenesis
The DOI matches its Crossref record; 124 of the 125 references it cites were found in a registry or an index.
Abstract
Multiple sclerosis (MS) is an autoimmune demyelinating disease and a common cause of neurological disability in young adults. The modest heritability of MS reflects complex genetic effects and multifaceted gene-environment interactions. The human leukocyte antigen (HLA) region is the strongest susceptibility locus for MS, but a genome-wide association study recently identified new susceptibility genes. Progress in high-throughput genotyping and sequencing technologies and a better understanding of the structural organization of the human genome, together with powerful brain-imaging techniques that refine the phenotype, suggest that the tools could finally exist to identify the full set of genes influencing the pathogenesis of MS.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“do not seem to have a significant genetic component”
Citations
Cites
Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429
Network biology: understanding the cell's functional organization
Barabási, A.-L., & Oltvai, Z. N. (2004) · Nature Reviews Genetics · doi:10.1038/nrg1272 · Cited by 7,903
Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease
Hugot, J.-P., Chamaillard, M., Zouali, H., Lesage, S., Cézard, J.-P., Belaiche, J., Almer, S., Tysk, C., O'Morain, C. A., Gassull, M., et al. (2001) · Nature · doi:10.1038/35079107 · Cited by 5,591
The Future of Genetic Studies of Complex Human Diseases
Risch, N., & Merikangas, K. (1996) · Science · doi:10.1126/science.273.5281.1516 · Cited by 5,355
A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease
Ogura, Y., Bonen, D. K., Inohara, N., Nicolae, D. L., Chen, F. F., Ramos, R., Britton, H., Moran, T., Karaliuskas, R., Duerr, R. H., et al. (2001) · Nature · doi:10.1038/35079114 · Cited by 5,030
A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis
Lennon, V. A., Wingerchuk, D. M., Kryzer, T. J., Pittock, S. J., Lucchinetti, C. F., Fujihara, K., Nakashima, I., & Weinshenker, B. G. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17551-x · Cited by 3,239
Genome-wide association studies for complex traits: consensus, uncertainty and challenges
McCarthy, M. I., Abecasis, G. R., Cardon, L. R., Goldstein, D. B., Little, J., Ioannidis, J. P. A., & Hirschhorn, J. N. (2008) · Nature Reviews Genetics · doi:10.1038/nrg2344 · Cited by 2,891
B-cell depletion with rituximab in relapsing-remitting multiple sclerosis
Hauser, S. L., Waubant, E., Arnold, D. L., Vollmer, T., Antel, J., Fox, R. J., Bar-Or, A., Panzara, M., Sarkar, N., Agarwal, S., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0706383 · Cited by 2,439 · cited 1×
“It is of considerable interest that a recent clinical trial of an anti-B-cell therapy in MS showed marked effects in reducing bursts of focal inflammatory disease activity, establishing the vital importance of B cells as triggers of MS attack”
BackgroundSelf-citationWacholder, S., Chanock, S., Garcia-Closas, M., El ghormli, L., & Rothman, N. (2004) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djh075 · Cited by 1,754
Risk Alleles for Multiple Sclerosis Identified by a Genomewide Study
(2007) · New England Journal of Medicine · doi:10.1056/nejmoa073493 · Cited by 1,746
Research works printed but not linked: 3
- Hauser, S. L. & Goodin, D. S. in Harrison's Principle of Internal Medicine 17th edn (eds Fauci, A. D. et al.) 2611–2620 (McGraw Hill, New York, 2008).
- Kantarci, O. H. et al. Men with MS transmit the disease more often to their children then women: the Carter effect. Mult. Scler. 10, S203 (2004).
- Anderson, A. & Karlsson J. Genetic of experimental autoimmune encephalomyelitis in the mouse. Arch. Immunol. Ther. Exp. (Warz) 52, 316–325 (2004).
Cited by
Items 101–200 of 347
Hashemi, B., Abdollahi, M., Abbaspour‐Aghdam, S., Hazrati, A., Malekpour, K., Meshgi, S., Kafil, H. S., Ghazi, F., Yousefi, M., Roshangar, L., et al. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.114195 · Cited by 52
X chromosome association testing in genome wide association studies
Hickey, P. F., & Bahlo, M. (2011) · Genetic Epidemiology · doi:10.1002/gepi.20616 · Cited by 52
Buck, D., Albrecht, E., Aslam, M., Goris, A., Hauenstein, N., Jochim, A., Cepok, S., Grummel, V., Dubois, B., Berthele, A., et al. (2012) · Annals of Neurology · doi:10.1002/ana.23749 · Cited by 53
Genome-Wide Association Study of Multiple Sclerosis Confirms a Novel Locus at 5p13.1
Matesanz, F., González‐Pérez, A., Lucas, M., Sanna, S., Gayán, J., Urcelay, E., Zara, I., Pitzalis, M., Cavanillas, M. L., Arroyo, R., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036140 · Cited by 58
“From a genetic point of view, MS is a complex disorder resulting from the combination of genetic and non-genetic factors [3].”
BackgroundCorreale, J., & Farez, M. F. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1301110 · Cited by 45
“The genetic component of MS is thought to derive from the presence of common allelic variants in several genes (2).”
BackgroundKumar, A., Cocco, E. E., Atzori, L., Marrosu, M. G., & Pieroni, E. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059711 · Cited by 44
“found to be strongly associated with MS susceptibility [3,4].”
BackgroundProstaglandins in pathogenesis and treatment of multiple sclerosis
Mirshafiey, A., & Jadidi‐Niaragh, F. (2010) · Immunopharmacology and Immunotoxicology · doi:10.3109/08923971003667627 · Cited by 47
“The incidence of MS in women is two-fold more than that in men and evidence exists for a cluster of disease in family.((11)) In the field of genetic factors, some genes have a significant role in the susceptibility to MS, such as genes related to hexose-6phosphate dehydrogenase, interferon regulatory factor 5, EVI5, S…”
BackgroundEpigenetic modifications and epigenetic based medication implementations of autoimmune diseases
Ahmadi, M., Gharibi, T., Dolati, S., Rostamzadeh, D., Aslani, S., Baradaran, B., Younesi, V., & Yousefi, M. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.12.072 · Cited by 44
Shih, B. B.-J., & Bayat, A. (2011) · Archives of Dermatological Research · doi:10.1007/s00403-011-1182-4 · Cited by 42
“This could potentially be involved in disease pathogenesis through autoimmunity or promote immune responses through the following mechanisms; presentation of disease-inducing antigen, presentation of antigens that share molecular mimicry or cross reactivity with disease-inducing antigen, or altered expression levels o…”
BackgroundKaushansky, N., Altmann, D. M., David, C. S., Lassmann, H., & Ben‐Nun, A. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-29 · Cited by 45
“In recent genome-wide association studies, several HLA and non-HLA genes have been associated with the disease, with the HLA-class II genes, particularly those of the HLA-DR15 haplotype (HLADQB1*0602- HLA-DQA1*0102; HLA-DRB1*1501; HLADRB5*0101) bearing the strongest association to MS [9,10].”
BackgroundRefining the association of MHC with multiple sclerosis in African Americans
McElroy, J. P., Cree, B., Caillier, S. J., Gregersen, P. K., Herbert, J., Khan, O. A., Freudenberg, J., Lee, A., Bridges, S. L., Hauser, S. L., et al. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq197 · Cited by 43
“94 × 10(281) (13); see (14,15) for review].”
Self-citationMultiple Lessons for Multiple Sclerosis
Hauser, S. L. (2008) · New England Journal of Medicine · doi:10.1056/nejme0806738 · Cited by 50
Self-citationMultiple Sclerosis: Autoimmune Disease or Autoimmune Reaction?
Stys, P. K. (2010) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100022393 · Cited by 41
Modifier Effects between Regulatory and Protein-Coding Variation
Dimas, A. S., Stranger, B. E., Beazley, C., Finn, R. D., Ingle, C., Forrest, M. S., Ritchie, M. E., Deloukas, P., Tavaré, S., & Dermitzakis, E. T. (2008) · PLoS Genetics · doi:10.1371/journal.pgen.1000244 · Cited by 41
“The case of MS clearly illustrates this: as with most complex disorders, MS has a polygenic heritable component characterised by underlying complex genetic architecture [18].”
BackgroundReplication of top markers of a genome-wide association study in multiple sclerosis in Spain
Cavanillas, M. L., Fernández, Ó., Comabella, M., Alcina, A., Fedetz, M., Izquierdo, G., Lucas, M., Cénit, M. C., Arroyo, R., Vandenbroeck, K., et al. (2010) · Genes and Immunity · doi:10.1038/gene.2010.52 · Cited by 44
Genetic burden in multiple sclerosis families
Isobe, N., Damotte, V., Re, V. L., Ban, M., Pappas, D. J., Guillot‐Noël, L., Cournu‐Rebeix, I., Compston, A., Mack, T. M., Cozen, W., et al. (2013) · Genes and Immunity · doi:10.1038/gene.2013.37 · Cited by 43
Self-citationAbdollahzadeh, R., Fard, M. S., Rahmani, F., Moloudi, K., Kalani, B. S., & Azarnezhad, A. (2016) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2016.05.053 · Cited by 42
The Genetics of Multiple Sclerosis
Didonna, A., & Oksenberg, J. R. (2017) · Codon Publications eBooks · doi:10.15586/codon.multiplesclerosis.2017.ch1 · Cited by 59
Self-citationSaberi, R., Sharif, M., Sarvi, S., Aghayan, S. A., Hosseini, S. A., Anvari, D., Nayeri, T., Hosseininejad, Z., & Daryani, A. (2018) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2018.06.011 · Cited by 39
BAK1 gene variation and abdominal aortic aneurysms
Gottlieb, B., Chalifour, L. E., Mitmaker, B., Sheiner, N., Obrand, D. I., Abraham, C., Meilleur, M., Sugahara, T., Bkaily, G., & Schweitzer, M. (2009) · Human Mutation · doi:10.1002/humu.21046 · Cited by 39
“KEY WORDS: intercellular gene variation; tissue specific gene alterations; abdominal aortic aneurysm; BAK1”
BackgroundLu, J., Joseph, J. T., Nash, R. A., Storek, J., Stevens, A. M., Metz, L. M., Clark, A. W., Johnson, E. S., & Yong, V. W. (2010) · Archives of Neurology · doi:10.1001/archneurol.2010.117 · Cited by 39
“Active (n=13)b 50 (10-134)c 62 (23-129)d 42 (12-133)c 49 (15-130)c 26 (22-30)c 19 (15-27)c”
InfluentialKiller cell immunoglobulin-like receptor genes in Spanish multiple sclerosis patients
García‐León, J. A., Pinto-Medel, M. J., Trujillo, L. G., Gomez, C. L., Oliver‐Martos, B., Prat-Arrojo, I., Marín-Bañasco, C., Suardíaz, M., Maldonado-Sánchez, R., Fernández-Fernández, Ó., et al. (2011) · Molecular Immunology · doi:10.1016/j.molimm.2011.05.018 · Cited by 38
Venkateswaran, S., & Banwell, B. (2010) · The Neurologist · doi:10.1097/nrl.0b013e3181c923d5 · Cited by 47
“Class II molecules are surface glycoproteins that present antigenic fragments to T cells, initiating an immune response.(131) Some studies have associated HLA-DR(15) with a younger onset of disease (early adulthood).”
BackgroundMultiple sclerosis is prominent in the Gulf states: Review
Mohammed, E. M. A. (2016) · Pathogenesis · doi:10.1016/j.pathog.2016.04.001 · Cited by 43
“frequently exposed to sunlight as a result of long winter months [5,27,54].”
BackgroundInfluentialImmunoregulatory Effects of Tolerogenic Probiotics in Multiple Sclerosis
Atabati, H., Yazdanpanah, E., Mortazavi, H., Bajestani, S. G., Raoofi, A., Esmaeili, S., Khaledi, A., Saburi, E., Afshari, J. T., Sathyapalan, T., et al. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-55035-6_6 · Cited by 40
EBV infection and HLA-DR15 jointly drive multiple sclerosis by myelin peptide presentation
Wang, J., Qiu, Y., Marti, Z., Li, F., Wacker, M., Oldrati, P., Mühlenbruch, L., Jin, L., Zhang, H., Xu, W., et al. (2026) · Cell · doi:10.1016/j.cell.2025.12.046 · Cited by 67
Sun, X., Qiu, W., Wang, J., Wang, S., Wang, Y., Zhong, X., Liu, C., Cui, C., Hong, H. Y., Yang, H., et al. (2020) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2019-322115 · Cited by 38
Wu, J.-S., Qiu, W., Castley, A. S. L., JAMES, I. R., Joseph, J. P., Christiansen, F., Carroll, W. M., Mastaglia, F. L., & Kermode, A. G. (2009) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2009.10.005 · Cited by 39
“Recent studies have shown that epistatic interactions between the two parental HLADRB1 allelesmay have an influence onMS susceptibility [10,11] aswell as modifying the clinical phenotype [12].”
BackgroundBen-Selma, W., Ben-Fredj, N., Chebel, S., Frih-Ayed, M., Aouni, M., & Boukadida, J. (2015) · International Journal of Immunogenetics · doi:10.1111/iji.12197 · Cited by 37
“However, it has been suggested to be affected by an interaction between genetic, environmental and geographical factors (Oksenberg et al., 2008; Bahreini et al., 2010; Zhang et al., 2011; Kauffman et al., 2012; Song et al., 2013).”
BackgroundBlood B Cell and Regulatory Subset Content in Multiple Sclerosis Patients
Deng, J. H. J. (2015) · Journal of Multiple Sclerosis · doi:10.4172/2376-0389.1000139 · Cited by 36
“Both environmental and genetic factors are important in disease onset and progression [1-4].”
BackgroundThe variation game: Cracking complex genetic disorders with NGS and omics data
Cui, H., Dhroso, A., Johnson, N. T., & Korkin, D. (2015) · Methods · doi:10.1016/j.ymeth.2015.04.018 · Cited by 42
Increased Risk of Autoimmune Disease in Families with Wegener’s Granulomatosis
Knight, A., Sandin, S., & Askling, J. (2010) · The Journal of Rheumatology · doi:10.3899/jrheum.091280 · Cited by 33
Progressive Multiple Sclerosis: Characteristics and Management
Hawker, K. (2011) · Neurologic Clinics · doi:10.1016/j.ncl.2011.01.002 · Cited by 42
Voracek, M., Loibl, L. M., Dervic, K., Kapusta, N. D., Niederkrotenthaler, T., & Sonneck, G. (2009) · Psychiatry Research · doi:10.1016/j.psychres.2008.10.032 · Cited by 33
“For instance, multiple sclerosis is only modestly heritable, but shows strong environmental effects (Oksenberg et al., 2008).”
Multiple Sclerosis: An Overview
(2015) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9781608059928115010014 · Cited by 32
Specificity of Adaptive Immune Responses in Central Nervous System Health, Aging and Diseases
Rickenbach, C., & Gericke, C. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.806260 · Cited by 37
Gene expression profiling in multiple sclerosis brain
Dutta, R., & Trapp, B. D. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.12.003 · Cited by 42
“The only consistent MS-associated gene is the HLA-DRB1 gene on chromosome 6p21 (Oksenberg et al., 2008), which accounts for 16–60% of the genetic susceptibility to MS (Haines et al.”
BackgrounddeLuca, L. S., Pikor, N. B., O’Leary, J., Galicia, G., Ward, L. A., Defreitas, D., Finlay, T. M., Ousman, S. S., Osborne, L. R., & Gommerman, J. L. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902881 · Cited by 40
Benedek, G., Meza-Romero, R., Jordan, K., Keenlyside, L., Offner, H., & Vandenbark, A. A. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0342-4 · Cited by 31
“Within this region, the highly polymorphic human leukocyte antigen (HLA) class II genes, such as HLADRB1 and HLA-DQB1, were associated with disease susceptibility [3–6].”
Toxoplasma gondii seropositivity is negatively associated with multiple sclerosis
Stascheit, F., Paul, F., Harms, L., & Rosche, B. (2015) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2015.05.011 · Cited by 31
“Autoimmune diseases like MS are currently considered to be caused by a combination of genetic susceptibility and environmental factors (Marrie, 2004; Oksenberg et al., 2008).”
BackgroundMultiple Sclerosis Genetics 2010
McElroy, J. P., & Oksenberg, J. R. (2011) · Neurologic Clinics · doi:10.1016/j.ncl.2010.12.002 · Cited by 35
“and haplotypic effects, complex epistatic interactions across the locus, and independent protective signals in the class I region.(1,2)”
Self-citationPerera, D., Stankovich, J. M., Butzkueven, H., Taylor, B. V., Foote, S. J., Kilpatrick, T. J., & Rubio, J. P. (2009) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2009.03.010 · Cited by 30
“Multiple sclerosis (MS) is the most common progressive neurological disease of young Caucasian adults and disease susceptibility is governed in part by genetic risk factors (Oksenberg et al., 2008).”
BackgroundPioneering discovery and therapeutics at the brain-vascular-immune interface
Akassoglou, K., Davalos, D., Mendiola, A. S., Petersen, M. A., Ryu, J. K., Schachtrup, K., & Yan, Z. (2024) · Cell · doi:10.1016/j.cell.2024.09.018 · Cited by 30
Kollaee, A., Ghaffarpor, M., Ghlichnia, H. A., Ghaffari, S. H., & Zamani, M. (2012) · International Journal of Immunogenetics · doi:10.1111/j.1744-313x.2012.01104.x · Cited by 33
“Tel: +98 21 88003812; Fax: +98 21 88003811, 88953005; E-mail: mzamani@sina.tums.ac.ir 414 autoreactive T lymphocytes (Oksenberg et al., 2008; Agrawal & Yong, 2007).”
Schaeffer, J., Cossetti, C., Mallucci, G., & Pluchino, S. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-398270-4.00030-6 · Cited by 29
Klotz, L., Farkas, M., Bain, N., Keskitalo, S., Semmler, A., Ineichen, B. V., Jelčić, I., Klockgether, T., Kölsch, H., Weller, M., et al. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.10.057 · Cited by 28
Mirshafiey, A., & Jadidi‐Niaragh, F. (2010) · Immunopharmacology and Immunotoxicology · doi:10.3109/08923970903283662 · Cited by 30
“evidence exists for clusters of disease within family [9].”
BackgroundTowards a comprehensive etiopathogenetic and pathophysiological theory of multiple sclerosis
Tobore, T. O. (2019) · International Journal of Neuroscience · doi:10.1080/00207454.2019.1677648 · Cited by 32
Monitoring of multiple sclerosis immunotherapy: From single candidates to biomarker networks
Goertsches, R. H., Hecker, M., & Zettl, U. K. (2008) · Journal of Neurology · doi:10.1007/s00415-008-6010-1 · Cited by 31
“MS is a polygenetic disease that involves the interplay of multiple genes, gene-gene interactions, and posttranscriptional regulatory mechanisms [4, 36]; hence these factors most probably contribute to clinical variability in disease presentation and in treatment effects.”
BackgroundFerlini, A., Bovolenta, M., Neri, M., Gualandi, F., Balboni, A., Yuryev, A., Salvi, F., Gemmati, D., Liboni, A., & Zamboni, P. (2010) · BMC Medical Genetics · doi:10.1186/1471-2350-11-64 · Cited by 29
“Background Although multiple sclerosis is the most prevalent neurological disease in the young adult population, it is catalogued as a neurodegenerative disorder of unknown aetiology [1].”
Vitamin D and multiple sclerosis.
Harandi, A. A., Harandi, A. A., Pakdaman, H., & Sahraian, M. A. (2014) · PubMed Central · Cited by 33
Ramil, E., Sánchez, A., González-Pérez, P., Antigüedad, A. R., Gómez‐Lozano, N., Ortiz, P., Arroyo, R., Heras, V. D. L., Vilches, C., & García-Merino, A. (2009) · Multiple Sclerosis Journal · doi:10.1177/1352458509355071 · Cited by 30
“The genetic area containing the CNR1 gene has not been identified in previous genome-wide scans as a locus related to MS susceptibility.(1) The weak association found in our study, restricted to a subgroup of patients, might explain in part this discrepancy.”
BackgroundHong, X., Wang, X., Rang, X., Yin, X., Zhang, X., Wang, R., Wang, D., Zhao, T., & Fu, J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.857014 · Cited by 26
Consequences of perinatal bisphenol A exposure in a mouse model of multiple sclerosis
Brinkmeyer‐Langford, C., Rodrigues, A., Kochan, K. J., Haney, R., Rassu, F. S., Steelman, A. J., Young, C. R., Riggs, P. K., Storts, R. W., Meagher, M. W., et al. (2013) · Autoimmunity · doi:10.3109/08916934.2013.832220 · Cited by 29
Restoring the balance between disease and repair in multiple sclerosis: insights from mouse models
Miller, R. H., & Fyffe-Maricich, S. L. (2010) · Disease Models & Mechanisms · doi:10.1242/dmm.001958 · Cited by 26
“In MS patients the onset of disease is difficult to determine, the disease progression varies, and the genetic linkage, while evident, is not easily defined (Oksenberg et al., 2008).”
The role of non-HLA single nucleotide polymorphisms in multiple sclerosis susceptibility
Bahreini, S. A., Jabalameli, M. R., Saadatnia, M., & Zahednasab, H. (2010) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2010.08.002 · Cited by 31
“Progress in high-throughput genotyping technologies and denser SNP maps has developed novel routes in determining the genes that have great potential to be involved in MS pathogenesis (Oksenberg et al., 2008).”
BackgroundPutative association of GPC5 polymorphism with the risk of inflammatory demyelinating diseases
Shin, J., Kim, H. J., Park, B. L., Bae, J. S., Kim, L. H., Cheong, H. S., & Shin, H. D. (2013) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2013.08.031 · Cited by 26
“In addition, IL2RA, IL7R, CD58, CLEC16A, DBC1, and GPC5 have been identified as factors influencing the pathogenesis of MS [8,16–21].”
BackgroundHelminth/Parasite Treatment of Multiple Sclerosis
Correale, J. D. (2014) · Current Treatment Options in Neurology · doi:10.1007/s11940-014-0296-3 · Cited by 29
Association to the Glypican-5 gene in multiple sclerosis
Lorentzen, Å. R., Melum, E., Ellinghaus, E., Smestad, C., Mero, I., Aarseth, J. H., Myhr, K., Celius, E. G., Lie, B. A., Karlsen, T. H., et al. (2010) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2010.07.003 · Cited by 26
“More recently, in genome-wide association studies (GWASs), nonHLA genes have repeatedly also been found to be associated with MS (Oksenberg et al., 2008).”
Kumar, A., Melis, P. M., Genna, V., Cocco, E. E., Marrosu, M. G., & Pieroni, E. (2014) · Molecular BioSystems · doi:10.1039/c4mb00203b · Cited by 24
Goertsches, R. H., Zettl, U. K., & Hecker, M. (2011) · Pharmacogenomics · doi:10.2217/pgs.10.190 · Cited by 25
Benedek, G., Paperna, T., Avidan, N., Lejbkowicz, I., Oksenberg, J. R., Wang, J., Brautbar, C., Israel, S., Miller, A., & for the Israeli MS Genetics group (2010) · Genes and Immunity · doi:10.1038/gene.2010.20 · Cited by 24
Self-citationCSF Proteomics Identifies Specific and Shared Pathways for Multiple Sclerosis Clinical Subtypes
Avşar, T., Durası, İ. M., Uygunoğlu, U., Tütüncü, M., Demirci, N. O., Saip, S., Sezerman, O. U., Sıva, A., & Turanlı, E. T. (2015) · PLoS ONE · doi:10.1371/journal.pone.0122045 · Cited by 24
“Genome-wide association and candidate gene studies have identified variants in numerous genes including IL2R, IL7R, HLA-DRB regions [10, 11], but still complete understanding of their causation is lacking, not only because of the issues relating to individual changes having low functional significance, but also due to…”
BackgroundJäger, J., Schulze, C., Rösner, S., & Martinꝉ, R. (2013) · Genes and Immunity · doi:10.1038/gene.2013.40 · Cited by 25
Kumar, A., Sechi, L. A., Caboni, P., Marrosu, M. G., Atzori, L., & Pieroni, E. (2015) · New Journal of Chemistry · doi:10.1039/c4nj01903b · Cited by 24
Ramagopalan, S. V., McMahon, R. M., Dyment, D. A., Sadovnick, A. D., Ebers, G. C., & Wittkowski, K. M. (2009) · BMC Medical Genetics · doi:10.1186/1471-2350-10-10 · Cited by 23
“Instead, amino acid 13 emerges as a more likely explanation for a disease association gradient [32].”
BackgroundCB1 receptor affects cortical plasticity and response to physiotherapy in multiple sclerosis
Mori, F., Ljoka, C., Nicoletti, C. G., Kusayanagi, H., Buttari, F., Giordani, L., Rossi, S., Foti, C., & Centonze, D. (2014) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000048 · Cited by 22
Tuller, T., Atar, S., Ruppin, E., Gurevich, M., & Achiron, A. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr281 · Cited by 22
ORIGINAL ARTICLE: Uterine Leiomyoma is Associated with a Polymorphism in the Interleukin 1‐β Gene
Pietrowski, D., Thewes, R., Sator, M. O., Denschlag, D., Keck, C., & Tempfer, C. M. (2009) · American Journal of Reproductive Immunology · doi:10.1111/j.1600-0897.2009.00718.x · Cited by 22
Kaushansky, N., & Ben‐Nun, A. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00280 · Cited by 23
Perspectives on the Use of Multiple Sclerosis Risk Genes for Prediction
Jafari, N., Broer, L., van Duijn, C. M., Janssens, A. C. J. W., & Hintzen, R. Q. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026493 · Cited by 24
“Also, integration of transcriptional, proteomics, and clinical factors will probably improve the prediction model and with that our understanding of MS genetics [34].”
BackgroundAnimal Models of Multiple Sclerosis
Sato, F., Omura, S., Martinez, N. E., & Tsunoda, I. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-384913-7.00004-6 · Cited by 20
Vitamin D receptor gene polymorphisms and the risk of multiple sclerosis: An updated meta-analysis
Chen, X., Zhang, M., Zhu, L., Peng, M., Liu, F., Zhang, G., Wang, L., & Zhao, J. (2017) · Microbial Pathogenesis · doi:10.1016/j.micpath.2017.08.002 · Cited by 21
Association analysis of nitric oxide synthases: NOS1, NOS2A and NOS3 genes, with multiple sclerosis
AlFadhli, S. M., Mohammed, E. M. A., & Al-Shubaili, A. (2013) · Annals of Human Biology · doi:10.3109/03014460.2013.786756 · Cited by 19
“Exacerbations of MS symptoms reflect inflammatory episodes and the neurodegenerative aspects of gliosis and axonal loss result in the progression of disability (Oksenberg et al., 2008).”
BackgroundB-cell delivered gene therapy for tolerance induction: Role of autoantigen-specific B cells
Zhang, A.-H., Li, X., Onabajo, O. O., Su, Y. A., Skupsky, J., Thomas, J. W., & Scott, D. W. (2010) · Journal of Autoimmunity · doi:10.1016/j.jaut.2010.05.002 · Cited by 19
“While there are several approved immune modulation treatments available for MS [9–12], the efficacy of these treatments is limited, and a majority of patients eventually will become disabled [13].”
BackgroundAdvances in Systems Biology Approaches for Autoimmune Diseases
Kim, H., Kim, H., & Lee, S. (2014) · Immune Network · doi:10.4110/in.2014.14.2.73 · Cited by 22
“About 100 disease-risk SNPs have been identified in celiac disease, Crohn’s disease (11), multiple sclerosis (12), psoriasis (13), rheumatoid arthritis (14,15), SLE (16), and type 1 diabetes (17).”
BackgroundKolln, J., Zhang, Y., Thai, G., Demetriou, M. A., Hermanowicz, N., Duquette, P., van den Noort, S., & Qin, Y.-F. (2010) · Journal of Immunology · doi:10.4049/jimmunol.0904083 · Cited by 16
Killer immunoglobulin-like receptor locus polymorphisms in multiple sclerosis
Jelčić, I., Hsu, K. C., Kakalacheva, K., Breiden, P., Dupont, B., Uhrberg, M., Martinꝉ, R., Münz, C., & Lünemann, J. D. (2011) · Multiple Sclerosis Journal · doi:10.1177/1352458511431726 · Cited by 25
The major cause of multiple sclerosis is environmental: genetics has a minor role - No
Sawcer, S. J. (2011) · Multiple Sclerosis Journal · doi:10.1177/1352458511421106 · Cited by 19
Self-citationMultiple sclerosis as a polygenic disease: An update
Favorova, O. O., Кулакова, О. Г., & Бойко, А. Н. (2010) · Russian Journal of Genetics · doi:10.1134/s1022795410030026 · Cited by 20
Genome-wide homozygosity and multiple sclerosis in Orkney and Shetland Islanders
McWhirter, R., McQuillan, R., Visser, E. M., Counsell, C. E., & Wilson, J. F. (2011) · European Journal of Human Genetics · doi:10.1038/ejhg.2011.170 · Cited by 20
Hamid, K. M., Nejati, A., Shoja, Z., Mollaei‐Kandelous, Y., Doosti, R., Mirshafiey, A., Tafakhori, A., Sahraian, M. A., & Marashi, S. M. (2016) · PubMed · Cited by 18
Sertbaş, M., & Ülgen, K. Ö. (2018) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2018.0088 · Cited by 19
TNFRSF1A, TRAPS and multiple sclerosis
Kümpfel, T., & Hohlfeld, R. (2009) · Nature Reviews Neurology · doi:10.1038/nrneurol.2009.154 · Cited by 20
González, G. M., Hart, B. A. ‘., Bugiani, M., Plemel, J. R., Schenk, G. J., Kooij, G., & Luchicchi, A. (2025) · Acta Neuropathologica · doi:10.1007/s00401-025-02923-1 · Cited by 21
“The HLA-DR15 haplotype, which contains the -DRB1*15:01 and -DRB5*01:01 alleles, represents the strongest genetic risk factor in Caucasian people with MS, with estimates of its contribution reaching up to 60% of the total hereditary predisposition [146].”
TRAIL/TRAIL Receptor System and Susceptibility to Multiple Sclerosis
Gomez, C. L., Fernández, Ó., García‐León, J. A., Pinto-Medel, M. J., Oliver‐Martos, B., Ortega-Pinazo, J., Suardíaz, M., Trujillo, L. G., Guijarro-Castro, C., Benito‐León, J., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021766 · Cited by 25
“Linkage and association studies demonstrate that MS follows a polygenic trait, with susceptibility being determined by different genes, each exerting a relatively moderate effect on overall disease predisposition [1].”
Brambilla, P., Esposito, F., Lindstrom, E., Sorosina, M., Giacalone, G., Clarelli, F., Rodegher, M., Colombo, B., Moiola, L., Ghezzi, A., et al. (2012) · Neuroscience Letters · doi:10.1016/j.neulet.2012.10.008 · Cited by 19
Weinstock‐Guttman, B., Zivadinov, R., Cutter, G., Tamaño‐Blanco, M., Marr, K., Badgett, D., Carl, E. M., Elfadil, M., Kennedy, C. L., Benedict, R. H. B., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016802 · Cited by 15
“These studies have confirmed key associations with the MHC locus and identified additional genetic variations associated with the risk of developing MS [10].”
BackgroundResultMultiple sclerosis genetics: Results from meta-analyses of candidate-gene association studies
Tizaoui, K. (2017) · Cytokine · doi:10.1016/j.cyto.2017.10.024 · Cited by 20
“Especially, HLADRB1∗1501 class-II allele accounts for less than 50% of MS genetics [7].”
InfluentialTiwari, S., Lapierre, J., Ojha, C. R., Martins, K., Parira, T., Dutta, R. K., Caobi, A., Garbinski, L. D., Ceyhan, Y., Esteban-López, M., et al. (2018) · Journal of Neuroscience Research · doi:10.1002/jnr.24322 · Cited by 21
“Predisposition to genetic changes and its effect on MS susceptibility was derived from the characteristics of familial aggregation and the amount of genetic information they share (Gejman, Sanders, & Duan, 2010; Oksenberg, Baranzini, Sawcer, & Hauser, 2008) .”
BackgroundProteomic Approaches to Decipher Mechanisms Underlying Pathogenesis in Multiple Sclerosis Patients
Singh, V. P., Tripathi, A. K., & Dutta, R. (2019) · PROTEOMICS · doi:10.1002/pmic.201800335 · Cited by 18
Ortíz, G. G., Torres-Mendoza, B. M., Ramírez-Jirano, L. J., Márquez-Pedroza, J., Hernández-Cruz, J. J., Mireles-Ramírez, M. A., & Torres-Sánchez, E. D. (2023) · Genes · doi:10.3390/genes14071319 · Cited by 19
“Furthermore, the HLA-DRB1*08 allele only modestly increases the risk of developing MS, and while associated with HLA-DRB1*15, the risk of MS doubles [52,53].”
BackgroundAllelic variation in the Tyk2 and EGF genes as potential genetic determinants of CNS repair
Bieber, A. J., Suwansrinon, K., Kerkvliet, J. G., Zhang, W., Pease, L. R., & Rodriguez, M. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0906589107 · Cited by 20
“One approach has focused on disease resistance and susceptibility, asking whether linkage exists between specific genetic loci and the presence or absence of disease (17, 18).”
BackgroundPhysiopathologie de la sclérose en plaques
Brassat, D. (2010) · La Presse Médicale · doi:10.1016/j.lpm.2009.12.001 · Cited by 30
The Double-Edged Sword of Autoimmunity: Lessons from Multiple Sclerosis
Hestvik, A. L. K. (2010) · Toxins · doi:10.3390/toxins2040856 · Cited by 21
“distance demonstrate the genetic contribution to MS [41].”
BackgroundImmune-cell crosstalk in multiple sclerosis
Ransohoff, R. M. (2018) · Nature · doi:10.1038/d41586-018-07063-z · Cited by 18
Rey, L. K., Wieczorek, S., Akkad, D. A., Linker, R. A., Chan, A., & Hoffjan, S. (2011) · Molecular and Cellular Probes · doi:10.1016/j.mcp.2011.05.004 · Cited by 20
Potential injectable hydrogels as biomaterials for central nervous system injury: A narrative review
Sarma, S., Deka, D. J., Rajak, P., Laloo, D., Das, T., Chetia, P., Saha, D., Bharali, A., & Deka, B. (2023) · Ibrain · doi:10.1002/ibra.12137 · Cited by 19
“42,43 The term “ stem cell therapy ” refers to a vast field that includes the therapeutic transplantation of numerous stem/progenitor cell types derived from diverse tissues into potential patients.”
BackgroundÇevik, B., Yığıt, S., Karakuş, N., Aksoy, D., Kurt, S. G., & Ates, O. (2014) · Journal of Investigative Medicine · doi:10.1097/jim.0000000000000107 · Cited by 19
“The human leukocyte antigen region is the strongest susceptibility locus for MS, but genome-wide association studies recently identified new susceptibility genes, each contributing a small to moderate effect to the overall disease predisposition.(6) Methylenetetrahydrofolate reductase (MTHFR) is a key enzyme-regulatin…”
BackgroundSotomayor, C. G., Velde‐Keyzer, C. A. T., de Borst, M. H., Navis, G. J., & Bakker, S. J. L. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9061911 · Cited by 19
Metadata
- Authors
- Oksenberg, J. R., Baranzini, S. E., Sawcer, S., & Hauser, S. L.
- Affiliations
- University of California, San Francisco (US)
- University of Cambridge (GB)
- Corresponding author
- Oksenberg, Jorge R.
- Hauser, Stephen L.
- Venue
- Nature Reviews Genetics
- Published
- 2008-06-10
- Volume
- 9
- Issue
- 7
- Pages
- 516-526
- ISSN
- 1471-0056 (ISSN-L)
- 1471-0064
- OpenAlex
- W1991500494
- Cited by
- 347
- References
- 125
- Citations by year
- 2026: 9 · 2025: 9 · 2024: 5 · 2023: 12 · 2022: 8 · 2021: 7 · 2020: 11 · 2019: 7 · 2018: 10 · 2017: 15 · 2016: 15 · 2015: 22 · 2014: 27 · 2013: 20 · 2012: 22
- FWCI
- 5.78
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Genetics (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Wellcome Trust
- Topics
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Keywords
- multiple sclerosis, genetic susceptibility, single nucleotide polymorphisms, genome-wide association study, HLA region, gene-environment interaction, autoimmune demyelinating disease, pathogenesis, susceptibility genes, neuroimaging
- MeSH terms
- Animals, HLA Antigens, Humans, Multiple Sclerosis, Genome, Human, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.